| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| BIAFbioAffinity Technologies, Inc. | 6.39M | 1.42 | -0.06 | 269.75% | -217.5% | -165.57% | 0.58 | |
| VNRXVolitionRx Limited | 35.61M | 0.29 | -0.94 | 59.1% | -15.54% | |||
| BDSXBiodesix, Inc. | 66.27M | 8.33 | -1.26 | 45.3% | -49.31% | -337.3% | 2.97 | |
| GRALGRAIL, Inc. | 3.8B | 97.44 | -1.53 | 34.9% | -286.43% | -18.14% | 0.03 | |
| GHGuardant Health, Inc. | 14.54B | 111.98 | -31.46 | 31.04% | -44.18% | -45.84% | ||
| ADVBAdvanced Biomed Inc. Common Stock | 6.86M | 0.32 | -67.45 | -135.32% | -77.48% | 0.00 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 14.61M | 55.55M | 93.11M | 125.59M |
| Revenue Growth % | - | - | - | - | 2.8% | 0.68% | 0.35% |
| Cost of Goods Sold | 0 | 0 | 0 | 114.61M | 172M | 188.72M | 203.62M |
| COGS % of Revenue | - | - | - | 7.84% | 3.1% | 2.03% | 1.62% |
| Gross Profit | 0 | 0 | 0 | -100M | -116.45M | -95.61M | -78.02M |
| Gross Margin % | - | - | - | -6.84% | -2.1% | -1.03% | -0.62% |
| Gross Profit Growth % | - | - | - | - | -0.16% | 0.18% | 0.18% |
| Operating Expenses | 287.5M | 255.66M | 316.42M | 1.17B | 5.33B | 1.42B | 2.11B |
| OpEx % of Revenue | - | - | - | 79.75% | 95.89% | 15.25% | 16.81% |
| Selling, General & Admin | 64.34M | 88.58M | 123.51M | 234.06M | 296.44M | 362.56M | 367.82M |
| SG&A % of Revenue | - | - | - | 16.02% | 5.34% | 3.89% | 2.93% |
| Research & Development | 223.16M | 167.09M | 192.91M | 460.21M | 329.58M | 338.75M | 322.38M |
| R&D % of Revenue | - | - | - | 31.5% | 5.93% | 3.64% | 2.57% |
| Other Operating Expenses | 0 | 0 | 0 | 471.07M | 4.7B | 718.47M | 1.42B |
| Operating Income | -287.5M | -255.66M | -316.42M | -1.27B | -5.44B | -1.52B | -2.19B |
| Operating Margin % | - | - | - | -86.6% | -97.98% | -16.28% | -17.43% |
| Operating Income Growth % | - | 0.11% | -0.24% | -3% | -3.3% | 0.72% | -0.44% |
| EBITDA | -273.42M | -245.36M | -308.85M | -1.21B | -5.29B | -1.36B | -2.03B |
| EBITDA Margin % | - | - | - | -82.6% | -95.2% | -14.57% | -16.17% |
| EBITDA Growth % | - | 0.1% | -0.26% | -2.91% | -3.38% | 0.74% | -0.5% |
| D&A (Non-Cash Add-back) | 14.08M | 10.31M | 7.56M | 58.45M | 154.76M | 158.7M | 158.06M |
| EBIT | -283.5M | -253.44M | -316.3M | -1.27B | -742.46M | -796.92M | -768.22M |
| Net Interest Income | 8.34M | 12.43M | 6.14M | 332K | 1.74M | 7.95M | 26.73M |
| Interest Income | 8.34M | 12.43M | 6.14M | 332K | 1.74M | 7.95M | 26.73M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 12.26M | 10.61M | 4.29M | 90K | 1.5M | 7.75M | 26.8M |
| Pretax Income | -275.23M | -245.05M | -312.12M | -1.27B | -5.44B | -1.51B | -2.16B |
| Pretax Margin % | - | - | - | -86.59% | -97.95% | -16.19% | -17.22% |
| Income Tax | 485K | -195K | 33K | -17.48M | -42.29M | -41.95M | -135.36M |
| Effective Tax Rate % | 1% | 1% | 1% | 0.99% | 0.99% | 0.97% | 0.94% |
| Net Income | -275.72M | -244.85M | -312.16M | -1.25B | -5.4B | -1.47B | -2.03B |
| Net Margin % | - | - | - | -85.39% | -97.19% | -15.74% | -16.14% |
| Net Income Growth % | - | 0.11% | -0.27% | -3% | -3.33% | 0.73% | -0.38% |
| Net Income (Continuing) | -275.72M | -244.85M | -312.16M | -1.25B | -5.4B | -1.47B | -2.03B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.42 | -1.99 | -2.52 | -40.18 | -173.87 | -47.20 | -63.54 |
| EPS Growth % | - | 0.18% | -0.27% | -14.94% | -3.33% | 0.73% | -0.35% |
| EPS (Basic) | -2.42 | -1.99 | -2.52 | -40.18 | -173.87 | -47.20 | -63.54 |
| Diluted Shares Outstanding | 114.14M | 123.19M | 123.67M | 31.05M | 31.05M | 31.05M | 31.9M |
| Basic Shares Outstanding | 114.14M | 123.19M | 123.67M | 31.05M | 31.05M | 31.05M | 31.9M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 649.23M | 557.51M | 595.92M | 242.73M | 295.63M | 156.06M | 819.86M |
| Cash & Short-Term Investments | 641.35M | 544.34M | 583.48M | 221.16M | 241.6M | 97.29M | 763.47M |
| Cash Only | 95.09M | 143.19M | 170.19M | 221.16M | 241.6M | 97.29M | 214.23M |
| Short-Term Investments | 546.26M | 401.15M | 413.29M | 0 | 0 | 0 | 549.24M |
| Accounts Receivable | 0 | 0 | 0 | 6.88M | 18.61M | 22.35M | 24.64M |
| Days Sales Outstanding | - | - | - | 171.91 | 122.31 | 87.63 | 71.61 |
| Inventory | 0 | 0 | 0 | 0 | 19.75M | 21.7M | 18.63M |
| Days Inventory Outstanding | - | - | - | - | 41.92 | 41.96 | 33.4 |
| Other Current Assets | 0 | 0 | 0 | 6.89M | 0 | 0 | 0 |
| Total Non-Current Assets | 37.61M | 78.01M | 110.38M | 9.5B | 5.31B | 4.4B | 2.16B |
| Property, Plant & Equipment | 33.04M | 59.46M | 101.39M | 216.37M | 198.72M | 169.38M | 135.43M |
| Fixed Asset Turnover | - | - | - | 0.07x | 0.28x | 0.55x | 0.93x |
| Goodwill | 0 | 0 | 0 | 6.2B | 1.5B | 888.94M | 0 |
| Intangible Assets | 0 | 0 | 0 | 3.07B | 2.94B | 2.69B | 2.02B |
| Long-Term Investments | 1.63M | 15.16M | 2.05M | 0 | 4.53M | 4.22M | 0 |
| Other Non-Current Assets | 2.94M | 3.38M | 6.94M | 7.1M | 6.14M | 7.98M | 11.12M |
| Total Assets | 686.85M | 635.52M | 706.3M | 9.74B | 5.6B | 4.56B | 2.98B |
| Asset Turnover | - | - | - | 0.00x | 0.01x | 0.02x | 0.04x |
| Asset Growth % | - | -0.07% | 0.11% | 12.79% | -0.42% | -0.19% | -0.35% |
| Total Current Liabilities | 74.16M | 44.93M | 83.97M | 97.89M | 134.94M | 163.61M | 76.92M |
| Accounts Payable | 12.75M | 6.09M | 24.51M | 17.65M | 17.48M | 19.67M | 4.84M |
| Days Payables Outstanding | - | - | - | 56.2 | 37.1 | 38.05 | 8.68 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 13.34M | 14.81M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 1000K |
| Other Current Liabilities | 267K | 23K | 12.41M | 4.51M | 65.96M | 87.64M | 22.69M |
| Current Ratio | 8.75x | 12.41x | 7.10x | 2.48x | 2.19x | 0.95x | 10.66x |
| Quick Ratio | 8.75x | 12.41x | 7.10x | 2.48x | 2.04x | 0.82x | 10.42x |
| Cash Conversion Cycle | - | - | - | - | 127.14 | 91.54 | 96.33 |
| Total Non-Current Liabilities | 12.32M | 40.06M | 60.49M | 209.51M | 821M | 747.13M | 402.98M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 800K | 36.64M | 57.54M | 96.75M | 82.67M | 69.6M | 54.88M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 735.19M | 676.03M | 345.86M |
| Other Non-Current Liabilities | 11.52M | 3.42M | 2.95M | 112.76M | 3.13M | 1.5M | 2.24M |
| Total Liabilities | 86.47M | 84.99M | 144.46M | 307.4M | 955.94M | 910.74M | 479.9M |
| Total Debt | 2.52M | 42.04M | 62.99M | 110.56M | 96.01M | 84.41M | 68.14M |
| Net Debt | -92.57M | -101.15M | -107.21M | -110.6M | -145.59M | -12.88M | -146.09M |
| Debt / Equity | 0.00x | 0.08x | 0.11x | 0.01x | 0.02x | 0.02x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - |
| Total Equity | 600.37M | 550.53M | 561.84M | 9.43B | 4.65B | 3.65B | 2.5B |
| Equity Growth % | - | -0.08% | 0.02% | 15.79% | -0.51% | -0.22% | -0.31% |
| Book Value per Share | 5.26 | 4.47 | 4.54 | 303.69 | 149.62 | 117.42 | 78.47 |
| Total Shareholders' Equity | 600.37M | 550.53M | 561.84M | 9.43B | 4.65B | 3.65B | 2.5B |
| Common Stock | 129K | 138K | 151K | 10.34B | 10.96B | 11.42B | 34K |
| Retained Earnings | -1.06B | -1.31B | -1.62B | -911.54M | -6.31B | -7.78B | -9.8B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 128K | 2.46M | 3.6M | 315K | 894K | 1.07M | 1.45M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Cash from Operations | -209.26M | -245.79M | -232M | -688.13M | -561.31M | -595.8M | -577.16M |
| Operating CF Margin % | - | - | - | -47.09% | -10.1% | -6.4% | -4.6% |
| Operating CF Growth % | - | -0.17% | 0.06% | -1.97% | 0.18% | -0.06% | 0.03% |
| Net Income | -275.72M | -244.85M | -312.16M | -1.25B | -5.4B | -1.47B | -2.03B |
| Depreciation & Amortization | 14.08M | 10.31M | 7.56M | 58.45M | 154.76M | 158.7M | 158.06M |
| Stock-Based Compensation | 11.04M | 28.39M | 45.99M | 681.91M | 75.73M | 97.23M | 86.08M |
| Deferred Taxes | 0 | 0 | 0 | 0 | -39.06M | -38.15M | -134.25M |
| Other Non-Cash Items | 1.66M | -353K | 9.38M | -201M | 4.66B | 644.38M | 1.36B |
| Working Capital Changes | 39.67M | -39.28M | 17.22M | 20.29M | -14.46M | 7.72M | -24.28M |
| Change in Receivables | 0 | 0 | 0 | -6.88M | -8.68M | -1.38M | -3.37M |
| Change in Inventory | 0 | 0 | 0 | -5.67M | -14.08M | -1.94M | 3.07M |
| Change in Payables | -338K | -6.55M | 0 | 0 | 2.34M | 2.89M | -14.63M |
| Cash from Investing | -93.39M | 133.04M | -12.79M | 344.81M | -22.86M | -12.89M | -551.01M |
| Capital Expenditures | -15.99M | -3.33M | -11.9M | -69.93M | -22.86M | -12.89M | -5.21M |
| CapEx % of Revenue | - | - | - | 4.79% | 0.41% | 0.14% | 0.04% |
| Acquisitions | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - |
| Other Investing | -77.4M | 136.37M | -885K | 414.74M | 0 | 0 | 0 |
| Cash from Financing | 300.62M | 160.33M | 275.11M | 394.74M | 604.82M | 463.77M | 1.24B |
| Debt Issued (Net) | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - |
| Other Financing | 302.13M | 161.88M | 275.92M | 388.93M | 604.82M | 463.77M | 1.24B |
| Net Change in Cash | - | - | - | - | - | - | - |
| Free Cash Flow | -225.25M | -249.13M | -243.91M | -758.06M | -584.17M | -608.69M | -582.36M |
| FCF Margin % | - | - | - | -51.88% | -10.52% | -6.54% | -4.64% |
| FCF Growth % | - | -0.11% | 0.02% | -2.11% | 0.23% | -0.04% | 0.04% |
| FCF per Share | -1.97 | -2.02 | -1.97 | -24.41 | -18.81 | -19.60 | -18.26 |
| FCF Conversion (FCF/Net Income) | 0.76x | 1.00x | 0.74x | 0.55x | 0.10x | 0.41x | 0.28x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -45.92% | -42.55% | -56.12% | -24.97% | -76.71% | -35.35% | -65.92% |
| Return on Invested Capital (ROIC) | -42.46% | -40.06% | -52.5% | -19.42% | -59.07% | -27.95% | -54.81% |
| Gross Margin | - | - | - | -684.39% | -209.63% | -102.69% | -62.12% |
| Net Margin | - | - | - | -8539.39% | -9719.35% | -1574.23% | -1613.92% |
| Debt / Equity | 0.00x | 0.08x | 0.11x | 0.01x | 0.02x | 0.02x | 0.03x |
| FCF Conversion | 0.76x | 1.00x | 0.74x | 0.55x | 0.10x | 0.41x | 0.28x |
| Revenue Growth | - | - | - | - | 280.17% | 67.61% | 34.9% |
| 2024 | |
|---|---|
| Americas | 108.54M |
| Americas Growth | - |
| Non-US | 14.69M |
| Non-US Growth | - |
GRAIL, Inc. (GRAL) reported $141.8M in revenue for fiscal year 2024.
GRAIL, Inc. (GRAL) grew revenue by 34.9% over the past year. This is strong growth.
GRAIL, Inc. (GRAL) reported a net loss of $406.2M for fiscal year 2024.
GRAIL, Inc. (GRAL) has a return on equity (ROE) of -65.9%. Negative ROE indicates the company is unprofitable.
GRAIL, Inc. (GRAL) had negative free cash flow of $329.8M in fiscal year 2024, likely due to heavy capital investments.